How many clinical trials are tracked of etrasimod?

9 trials are tracked, 2 with published results.

Mode

All Oncology Infectious Disease Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Primary Care & Family Medicine Gastroenterology Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Anesthesiology & Pain Medicine Genetics & Precision Medicine Pulmonology & Critical Care Physical Medicine & Rehab Nephrology Urology Emergency Medicine Ophthalmology Dermatology Hematology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

etrasimod

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of etrasimod

9 trials tracked of etrasimod: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 6 citations.

9Trials tracked

3Phase 3 & 4

0Recruiting

2With published results

Phase distribution

Phase 3 3 Phase 2 6

Phase 3 Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis Completed · 6 cited
Phase 3 Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis Completed · 6 cited
Phase 3 Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) Completed
Phase 2 A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis Completed
Phase 2 Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis Completed
Phase 2 Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata Completed

Show 3 more trials

Phase 2 Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis Completed
Phase 2 Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis Completed
Phase 2 Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.